Hypha’s paper in ACS Medicinal Chemistry Letters on “Biotransformation: Impact and Application of Metabolism in Drug Discovery” was published in August 2020. This article discusses the impact and application of biotransformation of drugs by mammalian systems, microorganisms, and recombinant enzymes, covering active and reactive metabolites, the impact of the gut microbiome on metabolism, and how insights gained from biotransformation studies can influence drug design from the combined perspectives of a CRO specializing in a range of biotransformation techniques, and pharma biotransformation scientists.

MetID Services Launch
Launch of New MetID Services Hypha Discovery is excited to announce that we have extended our metabolite identification services to include LC-MS/MS-based MetID, complementing our
Read More >

